President Joe Biden’s spotlight on his cancer moonshot and a proposed new research entity in the State of the Union address Tuesday signals the White House’s reliance on biomedical innovation as a vehicle to advance bipartisan initiatives through Congress.
Lawmakers told Bloomberg Government on Wednesday they’re hoping to fund a new medical research agency as part of a forthcoming FY 2022 spending bill, which must pass by March 11.
Biden ended his speech by outlining a new “unity” agenda with a heavy emphasis on health policies. It included ending the opioid epidemic, access to mental health care, improving the health ...